A couple nationwide
medication safety campaigns have been in the news lately. Earlier this year
ASHP (American Society of Health-System Pharmacists) was awarded a
3-year contract by the FDA to develop
standardized concentrations for intravenous and oral liquid medications. ASHP
has partnered with ISMP (Institute for Safe Medication Practices), AAMI
(Association for the Advancement of Medical Instrumentation), and PPAG
(Pediatric Pharmacy Advocacy Group) in this endeavor, the Standardize
4 Safety initiative. The coalition just announced one of its Phase 1 (of 3
Phases) outcomes: a list
of recommended standardized concentrations for adult continuous IV infusions.
The list includes the standardized concentration(s), dosing units, status of
commercial availability, and comments for over 30 of the most commonly infused
drugs in adults.
Other activities in
Phase 1 will be development and implementation of concentrations and dosing
units for compounded oral liquids for adults. Phase II addresses concentrations
and dosing units for pediatric continuous IV infusions and standard doses for
oral liquid medications. Phase III addresses intermittent IV medications, PCA
(patient-controlled analgesia) pumps, epidurals, and standard doses for oral
chemotherapy agents.
Another
collaborative medication safety campaign, the Just Bag It Campaign,
was just launched by the National Comprehensive Cancer Network (NCCN 2016). Vincristine is a
chemotherapy agent intended for intravenous use. Yet since the 1960’s there
have been numerous incidents where it has been administered intrathecally
or via Omaya reservoirs. The results are disastrous,
with patients developing quadriplegia, encephalopathy, and usually death. In
2013 ISMP summarized the literature (ISMP
2013) and noted that virtually all cases involved vincristine being
prepared in a syringe and that there were no cases when vincristine was
prepared in an IV bag. There are, of course, other contributing factors in such
incidents. ISMP noted the following contributing factors: mislabeling of
syringes; bringing IV and intrathecal medications into a treatment area
together; failing to administer vinca alkaloids in a
specialty oncology unit or with only experienced, oriented staff familiar with
current operational and clinical standards, procedures, or protocols;
administering chemotherapy outside of normal hours; not conducting an
independent double check or “time out” before intrathecal medication
administration; and incomplete or missing warning labels. But, given that all
reported incidents occurred when vincristine was in a syringe, ISMP recommended
that vincristine instead by diluted in a minibag for
infusion and syringes be avoided.
Now the NCCN Just Bag It Campaign has been launched for
the safe handling of vincristine, calling for health care professionals to always
dilute vincristine in a 50ml mini-IV drip bag and never in a syringe. The
campaign comes with Christopher’s Story, the sad story of a patient who died as
the result of one of the above vincristine errors. All NCCN member institutions
have already adopted this best practice for handling vincristine but the
campaign calls on all other oncology providers to do the same.
References:
ASHP (American Society of Health-System Pharmacists).
Standardize 4 Safety website.
http://www.ashp.org/menu/PracticePolicy/Standardize-4-Safety
ASHP (American Society of Health-System Pharmacists). ASHP
IV ADULT CONTINUOUS INFUSION GUIDELINES. October 2016
NCCN (National Comprehensive Cancer Network). Just Bag It: The NCCN Campaign for Safe
Vincristine Handling. NCCN 2016; accessed November 14, 2016
https://www.nccn.org/justbagit/
ISMP (Institute for Safe Medication Practices). Death and
neurological devastation from intrathecal vinca
alkaloids: Prepared in syringes = 120; Prepared in minibags
= 0. ISMP Medication Safety Alert! Acute Care Edition. September 5, 2013
https://www.ismp.org/newsletters/acutecare/showarticle.aspx?id=58
Print “December
2016 Standardize 4 Safety and Just Bag It!”
In our November 2015
What's New in the Patient Safety World column “Medications
Most Likely to Harm the Elderly Are…” we noted the paucity of evidence in
the literature about antibiotic stewardship programs in ambulatory care or
other outpatient settings. CDC had previously published on the core elements
for hospitals (CDC
2014) and nursing homes (CDC
2015). Now CDC has published the “Core Elements of Outpatient
Antibiotic Stewardship” (Sanchez
2016).
The Core Elements of Outpatient Antibiotic Stewardship are:
Regarding commitment,
CDC notes that declaring commitment to antibiotic stewardship in a public
fashion (eg. posters in examination rooms) has been
shown to reduce inappropriate prescription of antibiotics. In larger practices
and healthcare organizations, designating a leader for antibiotic stewardship
programs is recommended. CDC also recommends not only educating all staff on
antibiotic stewardship but also making it part of their job descriptions and evaluation.
CDC stresses that all members of the healthcare team have an important role in
antibiotic stewardship.
Under Action for
policy and practice they recommend adherence to the evidence-based
practices recommended in specialty society guidelines. They note that use of
delayed prescribing practices or watchful waiting, when appropriate, may be
successful strategies. This requires good communication skills and consistent
messages. Systems should provide clinical decision support tools for clinicians
and have informational printouts available for patients and families. Various
triage systems (eg. nurse call lines) should also
reinforce principles of appropriate antibiotic prescribing and may help reduce
unnecessary office/clinic/ER visits. They also recommend documentation in the
medical record of rationale for decisions not to prescribe antibiotics.
Tracking and
reporting consists of audit and feedback, which has been shown to reduce
inappropriate antibiotic prescribing. Items to track should include whether
antibiotics were appropriate, whether the correct antibiotic was prescribed,
and whether the duration of therapy recommended was appropriate. Some systems
or practices might choose a high priority condition, like acute bronchitis, to
monitor. Others might look at percentage of overall visits at which antibiotics
are prescribed. Feedback to individual prescribers can be compared to peers.
Some systems may also track adverse drug events related to antibiotics.
Education applies
both to prescribers and patients. Communication with patients or families
should take into account health literacy issues. Continuing educational
activities should be available for healthcare providers and timely access to
persons with expertise (eg. pharmacists, infectious disease staff) should be made
available.
See also our November
2015 What's New in the Patient Safety World column “Medications
Most Likely to Harm the Elderly Are…” for other recommendations and links
to some of the other studies on antibiotic stewardship in the outpatient
setting.
Some of our prior
columns on antibiotic stewardship:
References:
CDC. Core elements of hospital antibiotic stewardship
programs [Internet]. Atlanta, GA: US Department of Health and Human Services,
CDC; 2014; last updated May 25, 2016
http://www.cdc.gov/getsmart/healthcare/implementation/core-elements.html
CDC. Core elements of antibiotic stewardship for nursing
homes [Internet]. Atlanta, GA: US Department of Health and Human Services, CDC;
2015; last updated August 18, 2016
http://www.cdc.gov/longtermcare/prevention/antibiotic-stewardship.html
Sanchez GV, Fleming-Dutra KE, Roberts RM, Hicks LA. Core
Elements of Outpatient Antibiotic Stewardship. Recommendations and Reports.
MMWR 2016; 65(6): 1-12
http://www.cdc.gov/mmwr/volumes/65/rr/rr6506a1.htm?s_cid=rr6506a1_w
Print “December
2016 Update on Ambulatory Antibiotic Stewardship”
The Joint Commission
has revised for 2017 NPSG.07.06.01, its national patient safety goal for
prevention of CAUTI’s (catheter-associated urinary tract infections).
The elements of
performance for NPSG.07.06.01 are:
-
Limiting
use and duration
-
Performing
hand hygiene prior to catheter insertion or maintenance care
-
Using
aseptic techniques for site preparation, equipment, and supplies
-
Securing
catheters for unobstructed urine flow and drainage
-
Maintaining
the sterility of the urine collection system
-
Replacing
the urine collection system when required
-
Collecting
urine samples
(The NPSG acknowledges that there are certain medical conditions, predominantly
neurological ones, that require a prolonged use of an indwelling urinary
catheter in order to avoid adverse events and promote patient safety.)
-
Selecting
measures using evidence-based guidelines or best practices
-
Having a
consistent method for medical record documentation of indwelling urinary
catheter use, insertion, and maintenance.
-
Monitoring
compliance with evidence-based guidelines or best practices
-
Evaluating
the effectiveness of prevention efforts
(The NPSG notes that surveillance may be targeted to areas with a high volume
of patients using in-dwelling catheters, as identified through the hospital’s
risk assessment.)
Of course, we are
advocates of incorporating your evidence-based criteria into your CPOE system.
That can help ensure appropriate use of catheters and may help you meet some of
the documentation requirements. Innovative hospitals will also use barcoding to
help create documentation for things like time of insertion, review for
continuation, etc.
This NPSG and all
the other 2017 National Patient Safety Goals are now available on The Joint
Commission website (TJC
2016).
Our other columns on
urinary catheter-associated UTI’s:
References:
The Joint Commission. Hospital Accreditation Program. National
Patient Safety Goals Effective January 2017. Accessed November 18, 2016
https://www.jointcommission.org/assets/1/6/NPSG_Chapter_HAP_Jan2017.pdf
Print “December
2016 The Joint Commission NPSG for CAUTI’s”
ECRI Institute has published its annual list of its Top 10
Health Technology Hazards for 2017 (ECRI 2016). The full
report details the risks of each of the technologies and makes very useful
recommendations on what your organization should be doing to minimize those
risks. Their 2017 list:
As is our usual practice we don’t go into detail about items
on their list because we encourage you to go right to their excellent resources
on these topics. We’re happy to see that under alarm management they have highlighted
failures to communicate alarms effectively to staff, a topic we discussed in detail
in our February 9, 2016 Patient Safety Tip of the Week “It
was just a matter of time…”.
Go to the ECRI site to download the full
report. It is a free download but you’ll need to register to receive it.
References:
ECRI Institute. Top 10 Health Technology Hazards for 2017.
https://www.ecri.org/Pages/2017-Hazards.aspx
Print “December
2016 ECRI’s Top 10 Health Technology Hazards for 2017”
Print “December
2016 What's New in the Patient Safety World (full
column)”
Print “December
2016 Standardize 4 Safety and Just Bag It!”
Print “December
2016 Update on Ambulatory Antibiotic Stewardship”
Print “December
2016 The Joint Commission NPSG for CAUTI’s”
Print “December
2016 ECRI’s Top 10 Health Technology Hazards for 2017”
Print “PDF
version”
http://www.patientsafetysolutions.com/